{
  "denotations": [
    {
      "id": "T1",
      "obj": "Chemical",
      "span": {
        "begin": 5,
        "end": 17
      }
    },
    {
      "id": "T2",
      "obj": "Chemical",
      "span": {
        "begin": 22,
        "end": 81
      }
    },
    {
      "id": "T3",
      "obj": "Gene_or_protein",
      "span": {
        "begin": 22,
        "end": 54
      }
    },
    {
      "id": "T4",
      "obj": "Gene_or_protein",
      "span": {
        "begin": 84,
        "end": 88
      }
    },
    {
      "id": "T5",
      "obj": "Chemical",
      "span": {
        "begin": 84,
        "end": 93
      }
    },
    {
      "id": "T6",
      "obj": "Disease",
      "span": {
        "begin": 136,
        "end": 162
      }
    },
    {
      "id": "T7",
      "obj": "Disease",
      "span": {
        "begin": 165,
        "end": 170
      }
    }
  ],
  "sourcedb": "PubMed",
  "sourceid": "26481697_2",
  "text": "Both chemotherapy and epidermal growth factor receptor tyrosine kinase inhibitors ( EGFR TKIs ) are widely applied for the treatment of non-small cell lung cancer ( NSCLC ) , but the efficacy of these two treatments in combination is not yet clear ."
}
